Lilly Invests $2.1 Billion in New Indiana Facilities
US drugmaker Eli Lilly has announced plans to invest $2.1 billion to expand its manufacturing footprint by setting up two new sites in Boone County, Indiana. The facilities will expand Lilly’s network for active ingredients and new therapeutic modalities, such as genetic medicines, while also supporting increasing demand for its products.
“These new sites will add capacity in support of our growing pipeline of innovative medicines, while also creating more high-tech jobs for Hoosiers [people of Indiana]. We are pleased to be a founding investor at the LEAP Lebanon Innovation District,” said chairman and CEO David Ricks. The LEAP (Limitless Exploration/Advanced Pace (LEAP) Lebanon Innovation District is a new research park that is being established by the Indiana Economic Development Corporation.
The company said it aims to introduce four potential new medicines in the next two years, adding that it had delivered 17 new drugs during the past eight years. Lilly expects to create up to 500 new jobs as a result of the investment, which remains contingent upon local zoning and annexation approvals.
Lilly’s most recent expansion in Indiana was announced in 2019 and capped a series of investments in research and manufacturing in and around Indianapolis. Those investments totaled more than $2.5 billion over five years and have increased the total number of Lilly manufacturing employees to more than 3,700 in Indiana.
Author: Elaine Burridge, Freelance Journalist
